ABSTRACT-Decreased levels of endogenous hydrogen sulfide (H 2 S) contribute to atherosclerosis, whereas equivocal data are available on H 2 S effects during sepsis. Moreover, H 2 S improved glucose utilization in anaesthetized, ventilated, hypothermic mice, but normothermia and/or sepsis blunted this effect. The metabolic effects of H 2 S in large animals are controversial. Therefore, we investigated the effects of the H 2 S donor GYY4137 during resuscitated, fecal peritonitisinduced septic shock in swine with genetically and diet-induced coronary artery disease (CAD). Twelve and 18 h after peritonitis induction, pigs received either GYY4137 (10 mg kg
INTRODUCTION
Recent rodent studies have demonstrated that impaired endogenous hydrogen sulfide (H 2 S) production is implicated in the pathogenesis of atherosclerosis (1) . However, equivocal results are available on H 2 S levels in patients with coronary artery disease (CAD): both reduced (2) and increased H 2 S plasma levels (3) were described.
H 2 S was also reported to affect glucose metabolism: increased gluconeogenesis in hepatocytes following stimulation with sodium hydrosulfide (NaHS) was demonstrated in vitro (4), whereas cystathionine g-lyase (CSE) knockout mice revealed reduced gluconeogenesis (5) . Previously, we demonstrated that inhaled H 2 S increased glucose oxidation in anesthetized and mechanically ventilated mice during hypothermia, whereas both normothermia and/or sepsis blunted this effect (6) .
The vast majority of data on H 2 S with respect to glucose metabolism and cardiovascular properties originate from healthy small animal models, where H 2 S is able to induce profound hypometabolism (7). The metabolic properties of H 2 S in large animal models are controversial, inasmuch as both absence of metabolic effects (8-10) and reduced energy expenditure (11) were reported. Thus, the relevance and translatability of H 2 S effects reported in small animals have been questioned for large animal models or humans (6, 12) .
Due to the plethora of cardiovascular and metabolic effects of H 2 S, H 2 S-donating or inhibiting compounds are considered promising future therapeutic options. While inhalation of gaseous H 2 S is associated with pulmonary toxicity and airway irritation, intravenous application of sulfide salts faces extremely narrow timing and dosing margins (13) . GYY4137 (morpholin-4-ium-4-methoxyphenyl(morpholino) phosphinodithioate) is a slow-releasing H 2 S donor with improved pharmacokinetics and a more constant release of H 2 S compared with the instantaneous liberation by conventional sulfide salts (14) , thus more closely mimicking endogenous H 2 S release. GYY4137 demonstrated anti-inflammatory effects upon lipopolysaccharide (LPS) were recruited for the study. One pig from the vehicle group was excluded from the study, as it had not developed diffuse peritonitis upon necropsy. Moreover, the pig did not require norepinephrine support, and thus, by definition, did not develop septic shock. Subsequent data refer to the 17 pigs included in the data analysis. The FBM pig strain is a cross-bread of Rapacz pigs with smaller strains (Chinese Meishan and Bretoncelles), characterized by a homozygous R84C low-density lipoprotein receptor mutation, and develops marked atherosclerosis and consecutive CAD upon atherogenic diet (17) . Animals received the diet (1 kg daily, 1.5% cholesterol, 20% bacon fat) for at least 9 months prior to the experiments. The phenotype has been characterized previously. Briefly, FBM pigs on atherogenic diet exhibit significantly higher cholesterol levels compared to healthy German landrace swine of the same age. Plasma levels of isoprostanes are significantly increased, while plasma nitrite/nitrate levels are significantly lower than in healthy control strains. FBM pigs are also characterized by a significantly lower creatinine clearance compared to healthy German landrace swine (18) .
Anesthesia
Before the experiments, pigs were fasted for 12 h with free access to water. Intramuscular premedication consisted of 5 mg kg À1 azaperone. After establishment of an intravenous access via ear vein, anesthesia was induced with propofol (1-2 mg kg À1 ) and ketamine (1-2 mg kg À1 ). The pigs were endotracheally intubated and mechanically ventilated (tidal volume 8 mL kg À1 , respiratory rate 8-12 min À1 adapted to achieve an arterial pCO 2 of 35-40 mm Hg, inspiratory/expiratory (I/E) ratio 1:1.5, fraction of inspiratory oxygen (FiO 2 ) 30%, positive end expiratory pressure (PEEP) 10 cm H 2 O to prevent formation of atelectasis, peak airway pressure 40 mm Hg). Anesthesia was maintained with continuous intravenous infusion of pentobarbitone (8- , Jonosteril 1/1, Fresenius, Bad Homburg, Germany) were infused for fluid homeostasis. During surgery, hydroxyethyl starch 6% 130/0.42 (Vitafusal, Serumwerk, Bernburg, Germany) was used to maintain filling pressures. External heating allowed to control and maintain body core temperature at 37.5 to 38.58C.
Surgical procedures
The right internal jugular vein was exposed and a 9F central venous catheter sheath was inserted. The central venous catheter was subsequently used for infusion therapy and application of intravenous drugs. A balloon-tipped thermodilution pulmonary artery catheter was inserted via the sheath and used for the measurement of central venous pressure (CVP), mean pulmonary artery pressure (MPAP), pulmonary artery occlusion pressure (PAOP), and cardiac output (CO). One femoral artery and the left carotid artery were exposed for the placement of a PiCCO catheter for continuous cardiac output measurement and an 8F arterial catheter sheath, respectively. A pressure-conductance catheter (CD Leycom, Hengelo, The Netherlands) was inserted via the latter, and advanced into the left ventricle (LV) under control of the pressure curve. In order to determine kidney blood flow, a laparotomy was performed, and an ultrasonic flow probe was placed around the right kidney artery. Following exposure of a femoral vein, a 4F catheter was advanced into the inferior vena cava and guided into the right renal vein under manual and visual control. An indwelling catheter in the urinary bladder allowed urine collection. Two tubes were placed through the abdominal wall into the peritoneal cavity for subsequent induction of peritonitis.
Experimental protocol
After four hours of surgery, pigs were allowed to recover for 8 h before baseline data were collected. Subsequently, fecal peritonitis was induced. For this purpose, 1 g kg À1 autologous feces was collected during premedication, dissolved in 500 mL 0.9% saline, and incubated at 388C for 12 h. 3 mL kg À1 of the supernatant was injected into the peritoneal cavity via the abdominal tubes. Twelve and 18 h after induction of peritonitis, animals received bolus injections of 10 mg kg À1 GYY4137 (n ¼ 9) or vehicle (saline, n ¼ 8). GYY4137 was synthesized in-house as previously described (14) . Based on the time course of fecal peritonitis in previous sepsis studies of our group (19) , where norepinephrine requirements to maintain baseline MAP indicated the onset of sepsisinduced hemodynamic alterations after 6 to 9 h after peritonitis induction, the administration of GYY4137 was carried out as a ''therapeutic approach'' after development of sepsis. Balanced electrolyte solutions (20 
Measurements and calculations
Immediately before, 12 and 24 h after induction of fecal peritonitis, data sets were collected. Measurements included hemodynamics (MAP, MPAP, PAOP, CVP, heart rate, CO), gas exchange (calorimetric CO 2 production, arterial and mixed venous blood gases (p a O 2 , p a CO 2 )), pH, base excess, glucose, lactate, bhydroxybutyrate and the plasma levels of troponin, interleukin (IL)-6, IL-1b, tumor necrosis factor alpha (TNFa), nitrite plus nitrate (NO 2 À þ NO 3 À) and 8-isoprostane. The pressure-conductance catheter allowed assessment of systolic and diastolic LV function. Renal function was assessed by the determination of the following parameters: urine output, right kidney artery flow, renal venous blood gases, plasma creatinine and neutrophil gelatinase-associated lipocalin (NGAL) concentrations, and creatinine clearance.
Using a steady-state approach, endogenous glucose production was calculated after the determination of plasma glucose isotope enrichment by combined gas chromatography/mass spectrometry (GC/MS) and correction for exogenous glucose administration during continuous intravenous infusion of stable, non-radioactively labeled 1,2,3,4,5,6-13 C 6 -glucose (tracer). Pigs received an initial priming dose of 400 mg of tracer over 3 h. Subsequently, the tracer was continuously infused at a rate of approximately 0.025 mg kg CO 2 isotope in the expiratory gas using non-dispersive infrared spectrometry together with the calorimetric determination of total CO 2 production allowed the calculation of the percentage of oxidized tracer and total aerobic glucose oxidation rate (19) .
Free blood sulfide concentrations were determined by combined GC/MS (20) . Kidney and heart specimen were immediately collected post-mortem and analyzed for protein expression of heme oxygenase-1 (HO-1), B-cell lymphoma-extra large (Bcl-xL), inhibitor of nuclear factor kappa B (IkBa), the constitutive, endothelial, and the inducible isoforms of the nitric oxide synthase (eNOS, iNOS) by western blotting. Activation of the nuclear transcription factor kappa B (NF-kB) was assessed by electrophoretic mobility shift assay (EMSA). Actin and vinculin served as loading controls. For comparison between individual gels, the intensity of each band was related to that of the mean of two native animals, which had not undergone surgical instrumentation and fecal peritonitis. Western blots were run at least in triplicates. The mean value of the individual gels for each animal was used for quantitative analysis, and data are reported as fold increase over the mean of the two native animals. Supplemental figure 1, http://links.lww.com/SHK/ A550, shows original western blots and EMSA for kidney (A) and heart (B) of all individual animals.
Additional heart and kidney specimens were taken for immunohistochemistry analysis of 3-nitrotyrosine formation, expression of the endogenous H 2 Sproducing enzyme CSE, and extravascular albumin. Therefore, specimen were fixed in formalin, embedded in paraffin, dewaxed in xylene, and rehydrated with a graded series of ethanol. After incubation in citrate buffer and boiling for heat-induced antigen retrieval, samples were blocked with goat sera and subsequently incubated with primary anti-nitrotyrosine (polyclonal rabbit; Merck Millipore, Darmstadt, Germany), anti-CSE (monoclonal mouse; Abnova, Taipei City, Taiwan), or anti-albumin antibodies (polyclonal rabbit; Abcam, Cambridge, UK). Primary antibody detection was performed by using the Dako REAL Detection system/RED (Dako Deutschland GmbH, Hamburg, Germany), followed by counterstaining with hematoxylin. Slides were visualized using a Zeiss Axio Imager A1 microscope with a Â10 objective. Quantification for intensity was performed using the AxioVision 4.8 software (Zeiss, Jena, Germany). Results are presented as mean densitometric sum red (19) .
Mitochondrial respiratory activity was analyzed via ''high-resolution respirometry'' using the Oroboros Oxygraph-2K (Oroboros Instruments, Innsbruck, Austria) in homogenized cardiac, renal, and hepatic tissue specimens collected at the end of the experiment. After supplementation of substrates for complexes I and II and ADP, maximal oxidative phosphorylation (in the coupled state, OxPhos) was assessed. Maximal respiratory capacity of the electron transfer system (ETS) in the uncoupled state was measured after addition of 4-(trifluoromethoxy) phenylhydrazone (FCCP). Additionally, LEAK respiration compensating for proton leakage or slipping was reported as percentage of ETS capacity (21) .
Statistical analysis
All data are expressed as median (IQR) unless otherwise stated. The effects of GYY4137 were analyzed using repeated measures (RM) two-way ANOVAs. P values for effects of time and treatment are reported in the data tables.
Subsequent post-hoc testing within the ANOVAs was corrected for multiple comparisons (Sidak method). As GYY4137 was administered 12 and 18 h after the induction of fecal peritonitis, i.e., after the 12 h time point, the ANOVAs were performed with the 12 h time point as baseline (before administration of GYY4137) and the 24 h time point (after administration of GYY4137). Intergroup differences of data with only one data set (e.g., histology at the end of the experiments, etc.) were analyzed by the Mann-Whitney rank sum test. A P value of less than 0.05 was considered statistically significant. GraphPad Prism 7 software was used for statistical evaluation and graphical display. A statistical sample size calculation based on creatinine levels and norepinephrine requirements of a previous study (13) and a power of 80% yielded a minimum of n ¼ 8 animals per group. In order to compensate for non-normal distribution of parameters, n ¼ 9 animals were recruited per group. The results should be interpreted carefully in an explorative manner due to the small sample size and the multitude of analyzed variables. MPAP, PAOP) were also similar between groups. P a O 2 and the p a O 2 to FiO 2 ratio significantly declined after 24 h, again without any intergroup differences. Metabolic data before induction of fecal peritonitis comprising temperature, pH, base excess, plasma lactate, b-hydroxybutyrate (Table 1) , blood glucose, endogenous glucose production, glucose oxidation, and CO 2 production from glucose oxidation (Fig. 1) were similar in the two groups. Endogenous glucose release slightly increased after 12 h of peritonitis induction, and thereafter even decreased again in both groups (Fig. 1) . After administration of GYY4137, pigs showed significantly higher tracer oxidation (P ¼ 0.041) and total glucose oxidation rate (P ¼ 0.020) at 24 h compared to control animals, resulting in significantly higher requirement of exogenous glucose administration to maintain normoglycemia (P ¼ 0.018) (Fig. 1) . While total CO 2 production remained constant in both groups between 12 and 24 h after induction of fecal peritonitis (Table 1) , the fraction of CO 2 production from glucose oxidation was significantly higher at 24 h in the GYY4137-treated animals (P ¼ 0.031, Fig. 1 ).
RESULTS
Both arterial pH and base excess decreased after infusion of GYY4137 (P < 0.001 and P ¼ 0.051, respectively). PH was significantly lower compared with vehicle at 24 h (P < 0.001), whereas lactate levels were comparable (Table 1) . Plasma sulfide levels did not significantly differ in the two groups either (Table 2) . Table 3 demonstrates that blood biomarkers of inflammation and oxidative stress as well as nitrite/nitrate plasma levels did not significantly differ after 24 h. However, blood isoprostanes were higher in the GYY4137 group 12 h after induction of peritonitis, i.e., prior to the first injection of GYY4137.
Parameters of left ventricular function did not reveal substantial intergroup differences. However, troponin levels significantly increased in the GYY4137-treated pigs compared with before treatment (P ¼ 0.01) and were higher than in the control group at 24 h (P ¼ 0.059, Table 4 ). While cardiac BclxL and HO-1 showed a non-significant trend toward reduced expression (both P ¼ 0.07), cardiac eNOS expression was significantly lower upon GYY4137 treatment (P ¼ 0.001, Fig. 2) .
Apart from lower renal venous base excess (P ¼ 0.001) in the GYY4137 group at 24 h, analysis of kidney function (Table 5) and quantitative analysis of western blots for renal Bcl-xL, HO-1, IkBa, and iNOS expression as well as EMSA for NF-kB activation (Fig. 3) did not show any further significant intergroup differences. Immunohistochemistry for renal and cardiac CSE expression, nitrotyrosine formation, and extravascular albumin (Fig. 4) , as well as mitochondrial respiratory capacity (Oxphos, ETS, LEAK/ETS) of cardiac, renal or hepatic tissue specimens (supplemental Table 1 , http://links.lww.com/SHK/A551) did not show any significant intergroup differences, either.
DISCUSSION

Metabolic effects
In the present study, we investigated the effects of the slowreleasing hydrogen sulfide donor GYY4137 in a porcine model of resuscitated septic shock with pre-existing CAD. The main findings were significantly increased glucose oxidation (Fig. 1) and reduced arterial pH as well as base excess (Table 1) in the GYY4137-treated pigs. As total CO 2 production did not increase, the higher glucose oxidation in the GYY4137 group supports the notion that GYY4137 treatment resulted in preferential carbohydrate utilization. Consistently inhaled hydrogen sulfide also increased aerobic glucose oxidation in anesthetized and mechanically ventilated, ). F, CO 2 production from glucose oxidation (%). Boxplots display median, quartiles, and range. GYY4137 was administered 12 and 18 h after induction of fecal peritonitis, i.e., after the 12 h time point. vehicle: n ¼ 8; GYY4137 n ¼ 8; n ¼ 7 for endogenous glucose production. hypothermic mice (6) . Interestingly, in that study, normothermia and/or sepsis blunted the shift in substrate utilization. As both the metabolic rates and the metabolic response to stress substantially vary between small and large animals, interspecies differences might be responsible for the heterogeneous effects. Small rodents are able to rapidly reduce their oxygen consumption and typically drop their core temperature in response to stress by reducing non-shivering thermogenesis without affecting ATP generation (6, 12) , and H 2 S-induced hypometabolism is well described (7, 22) . In contrast, the decrease of the metabolic rate upon H 2 S treatment remains a matter of debate in large animals or humans. In line with previous studies in pigs (9) or sheep (8, 10), H 2 S-induced hypometabolism was absent in our study. Of note, while data from large animals were collected under anesthesia, the metabolic effects of H 2 S in small mammals were predominantly reported in awake, spontaneously breathing mice (7) or rats (22) . General anesthesia seems at least to attenuate hypometabolic effects of H 2 S in mice (6) . Several studies demonstrated effects of H 2 S on glucose metabolism. Stimulation of hepatocytes with NaHS impaired glucose utilization and increased gluconeogenesis in vitro (4), whereas genetic knockout of CSE decreased gluconeogenesis in mice (5) . In cultured cardiomyocytes, NaHS supported glucose uptake and metabolism (23) . Thus, H 2 S might function as a provider of increased carbohydrate substrate availability by increasing hepatic glucose synthesis and by facilitating glucose utilization by other organs. Moreover, GYY4137 has been shown to inhibit lipolysis in vivo in mice receiving a high fat diet (24) , further supporting a H 2 S-induced shift in substrate utilization. Any shift toward carbohydrate oxidation entails an improved yield of the oxidative phosphorylation, as the net ATP production per mole of consumed oxygen is higher for carbohydrate than lipid oxidation (25).
FIG. 2.
Quantitative analysis of western blots and electrophoretic mobility shift assay (EMSA) for Nf-kB of heart specimens collected at the end of the experiment. For comparison between individual gels, the intensity of each band was related to that of the mean of two native animals, which had not undergone surgical instrumentation and faecal peritonitis. The mean value of the individual gels for each animal was used for quantitative analysis, and data are reported as fold increase over the mean of the two native animals. Boxplots display median, quartiles, and range. Vehicle: n ¼ 8 animals; GYY4137 n ¼ 7. Bcl-xL indicates B-cell lymphoma-extra large; eNOS, endothelial isoform of the nitric oxide synthase; HO-1, heme oxygenase-1; IkBa, inhibitor of nuclear factor kappa B; iNOS, inducible isoforms of the nitric oxide synthase; NF-kB, nuclear transcription factor kappa B.
Besides the influence of GYY4137 on glucose oxidation, pH was significantly lower at 24 h of sepsis, and base excess decreased in the GYY4137 group. In contrast, plasma lactate levels were comparable (Table 1) . Hence, analyzing the strong ion difference (SID), the lactate levels could not account for the lower base excess. Accumulation of unmeasured acids such as free fatty acids due to the metabolic shift toward glucose utilization would be conceivable. However, b-hydroxybutyrate did not significantly differ among groups and even decreased at the end of the experiment in the GYY group (Table 1) . As both inhibitory and stimulatory effects of hydrogen sulfide on mitochondrial respiration have been described (26), we further excluded a possible toxic effect of GYY4137 on the mitochondrial respiratory capacity (supplemental Table 1 , http://links. lww.com/SHK/A551) as cause for the metabolic acidosis. Importantly, the mitochondrial results need to be interpreted very carefully: on the one hand, sample treatment and ex-vivo conditions might have blunted potential in vivo effects. On the other hand, as GYY4137 is not specifically targeted to the mitochondria, the amount of H 2 S reaching the mitochondria might have been too low to provoke substantial effects. The effects of GYY4137 on the acid-base state remain elusive so far and deserve future investigation.
Non-metabolic results
Troponin levels were higher in the GYY4137 group at 24 h (Table 4) . However, a trend toward increased troponin was already present 12 h after induction of fecal peritonitis, i.e., prior to the injection of GYY4137. At that time point, plasma levels of 8-isoprostane were also higher than in the control group (Table 3 , P ¼ 0.049). Moreover, cardiac HO-1 expression was lower in the GYY4137-treated pigs (Fig. 2) . Finally, despite overall comparable doses of norepinephrine, the GYY4137-treated animals showed a tendency to increased cumulative doses of norepinephrine within the first 12 h after induction of (0.61 (0.56; 0.79) versus 0.36 (0.28; 0.81) mg kg À1 min
À1
; P ¼ 0.11). Thus, both more pronounced oxidative stress and enhanced myocardial O 2 demand resulting from higher norepinephrine needs might explain the increased troponin levels independently of GYY4137. After administration of GYY4137, 8-isoprostane levels slightly decreased supporting a previously described antioxidative role of GYY4137 in the heart (27) . However, in contrast to studies in rodents reporting both NOdependent and NO-independent cardioprotective effects of GYY4137 (28, 29) , myocardial eNOS expression was significantly lower in the GYY4137-treated animals (Fig. 2) . Consequently, reduced local availability of NO might have further contributed to cardiac injury. Of note, troponin levels were also elevated in a dose-dependent manner in a porcine model of cardiac arrest and resuscitation during supplementation of Na 2 S (30). Interspecies differences or the pre-existing cardiac comorbidity might account for the different results.
In contrast to conventional sulfide donors (gaseous application, sulfide salts), GYY4137 more consistently displayed anti-inflammatory features in previous studies, both in vitro and in vivo (15, 16) . Moreover, GYY4137 reduced kidney and liver damage during endotoxic shock in vivo (15) . These antiinflammatory and organ-protective properties of GYY4137 could not be demonstrated in the present study. However, all previous data on organ-protective effects of GYY4137 originate from studies in small mammals. Furthermore, intensive care measures and, in particular, the high-dose vasopressor support may have blunted potential GYY4137-mediated effects, as norepinephrine is well established to have prooxidant properties, especially in the heart (31), and existing murine studies do not comprise standard ICU and catecholamine therapy. The pre-existing atherosclerotic comorbidity might also be accountable for the discrepant results. Decreased endogenous H 2 S production has been implicated in the development of atherosclerosis (1) . Finally, the most important aspects to consider are timing and dosing of GYY4137. As no studies about GYY4137 in large animals have been reported so far, dosing of GYY4137 was selected according to previous rodent experiments (14) . In the initial study characterizing the novel compound GYY4137, a low dose of 26.6 mmol kg
already caused a fall in MAP of more than 5 mm Hg in rodents (14) . In the present study, two boli of 10 mg kg À1 (26.6 mmol kg À1 ) GYY4137 were administered 12 and 18 h after peritonitis induction, and higher doses were not used in order to avoid aggravation of sepsis-induced hypotension due to vasodilatory effects of H 2 S. Hence, the dose of GYY4137 may have limited the findings with respect to anti-inflammatory and organprotective properties, and higher doses might have yielded further results, especially as H 2 S liberation from GYY4137 has been shown to be rather slowly and less efficient compared with novel compounds (32) . In addition, timing represents a crucial aspect for the efficacy of GYY4137 and H 2 S-based therapies (13) . The anti-inflammatory and organ-protective properties of GYY4137 in endotoxic shock in rats could only be seen when GYY4137 was given shortly (1 or 2 h) after LPS injection, whereas a pretreatment design failed to induce significant anti-inflammatory effects (15) . Due to temporal differences in the evolution of sepsis-induced alterations between the rodent model of endotoxic shock and our porcine model of fecal peritonitis, GYY4137 was given 12 and 18 h after induction of peritonitis in the present study, when sepsis had fully developed. Thus, the dose of GYY4137 and the clinically relevant posttreatment administration of GYY4137 FIG. 3 . Quantitative analysis of western blots and electrophoretic mobility shift assay (EMSA) for Nf-kB of kidney specimens collected at the end of the experiment. A, Bcl-xL. B, HO-1. C, IkBa. D, iNOS. E, NF-kB. For comparison between individual gels, the intensity of each band was related to that of the mean of two native animals, which had not undergone surgical instrumentation and fecal peritonitis. The mean value of the individual gels for each animal was used for quantitative analysis, and data are reported as fold increase over the mean of the two native animals. Boxplots display median, quartiles, and range. Vehicle: n ¼ 8; GYY4137 n ¼ 9. Bcl-xL indicates B-cell lymphoma-extra large; HO-1, heme oxygenase-1; IkBa, inhibitor of nuclear factor kappa B; iNOS, inducible isoforms of the nitric oxide synthase; NF-kB, nuclear transcription factor kappa B.
might account for the absence of anti-inflammatory and organprotective results in the present study.
Measurement of free blood sulfide levels did not reveal significant differences between the GYY4137 and the control group (Table 2) . However, application of exogenous H 2 S is not necessarily reflected in increased free sulfide blood levels due to the high sulfide-binding capacity of blood (33) . Spiking of blood samples ex vivo with sodium sulfide to reach a target concentration of 100 mM only increased sulfide blood levels to about 20 mM (20) . Moreover, in a previous study from our group, infusion of sodium sulfide attenuated kidney injury and reduced the inflammatory response after aortic occlusion, although blood sulfide levels were hardly affected (34) . Thus, measured free blood sulfide levels do not need to correlate with biological effects, either, as H 2 S-mediated effects might be due to intracellular H 2 S, which is not detected by blood measurements. As the present study is the first to evaluate the effects of GYY4137 in swine, we cannot be certain whether the effects were due to intra-or extracellular H 2 S generated from GYY4137, and in our in vivo study it was not possible to determine intracellular H 2 S production. However, given the numerous previously described intracellular effects of GYY4137-derived H 2 S (32) and the rapid rate of exogenous H 2 S removal in blood (e.g., scavenging by hemoglobin, etc.) together with the unaffected, measured blood sulfide levels, it is most likely, that the observed effects were due to intracellular H 2 S released from GYY4137 rather than extracellular H 2 S.
Limitations
As GYY4137 is a slow-releasing H 2 S donor, which releases H 2 S via hydrolysis, we cannot exclude the possibility that the experimental results are influenced by either the mother substance itself or the residual molecule after H 2 S liberation (''decomposed'' GYY4137) (35) . However, as a similar metabolic shift toward preferential carbohydrate utilization has been reported with inhaled H 2 S in mice (6), the present results are most likely attributable to the released H 2 S. Furthermore, ''decomposed'' GYY4137 did not exert similar cellular effects in vitro and in vivo compared with the original compound (15, 35) , suggesting that the present results are due to GYY4137-derived H 2 S. However, as discussed above, the dosage of GYY4137 might have limited the findings with respect to previously described anti-inflammatory or organ-protective properties and future studies in large animals should take higher dosing into account. Moreover, the metabolic properties with regard to glucose oxidation already slightly (but non-significantly) differed between the GYY4137 and the control group at the 12 h time point before the application of GYY4137. Because of the small number of animals, we cannot fully exclude the possibility that the effects reported for GYY4137 at 24 h were due to uneven group distribution. Future studies need to validate the reported effects of GYY4137 in larger cohorts.
Another potential limitation represents the pre-existing cardiovascular comorbidity of the FBM swine. As previously reported effects of GYY4137 were evaluated in vitro and in healthy in vivo models, the pre-existing hypercholesterolemia and CAD in our model might have influenced the effects of GYY4137 compared with healthy pigs.
CONCLUSION
To the best of our knowledge, this is the first study to evaluate effects of the slow-releasing H 2 S donor GYY4137 in large animals. During resuscitated septic shock in swine with pre-existing atherosclerosis-induced CAD, GYY4137 shifted metabolism to preferential carbohydrate utilization under controlled normothermia and reduced arterial pH. Previously reported anti-inflammatory and organ-protective properties of GYY4137 in rodents could not FIG. 4 . Immunohistochemistry of heart and kidney specimens collected at the end of the experiment. A, CSE. B, 3-nitrotyrosine. C, extravascular albumin. Quantitative results of densitometric analysis. Boxplots display median, quartiles, and range. Vehicle: n ¼ 8 animals (except for heart (albumin): n ¼ 7); GYY4137 n ¼ 8 for heart, n ¼ 9 for kidney. CSE indicates cystathionine g-lyase.
be demonstrated most likely due to different timing and dosing of GYY4137. Increased troponin levels might be due to reduced local availability of NO and deserve further investigation.
